Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: Integrated analysis

Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Hilde de Winter, Filip Callewaert

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: Integrated analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences